Clinical trial
Antiviral Therapy in Infants With HBV Infection
NCT06503796 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiviral Therapy in Infants With HBV Infection
- Lead sponsor
- Beijing 302 Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- August 31, 2024
- Completion date
- November 30, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hbv